| | | | | | | | | | | | |
Security | | Par (000) | | | Value | |
|
Asset-Backed Securities | |
AGL CLO Ltd., Series 2021-12A, Class B, (3-mo. CME Term SOFR + 1.86%), 7.18%, 07/20/34(a)(b) | | | USD | | | | 1,000 | | | $ | 999,209 | |
Anchorage Capital CLO Ltd., Series 2019-11A, Class A, (3-mo. CME Term SOFR + 2.56%), 7.88%, 07/22/32(a)(b) | | | | | | | 1,000 | | | | 1,000,019 | |
Bain Capital Credit CLO Ltd.(a)(b) | | | | | | | | | | | | |
Series 2019-2A, Class CR, (3-mo. CME Term SOFR + 2.36%), 7.68%, 10/17/32 | | | | | | | 1,000 | | | | 997,874 | |
Series 2021-4A, Class B, (3-mo. CME Term SOFR + 1.91%), 7.23%, 10/20/34 | | | | | | | 1,000 | | | | 994,470 | |
Series 2021-6A, Class B, (3-mo. CME Term SOFR + 1.91%), 7.23%, 10/21/34 | | | | | | | 1,500 | | | | 1,492,915 | |
Ballyrock CLO Ltd.(a)(b) | | | | | | | | | | | | |
Series 2019-2A, Class BRR, (3-mo. CME Term SOFR + 2.40%), 7.62%, 02/20/36 | | | | | | | 1,000 | | | | 1,001,120 | |
Series 2021-1A, Class B, (3-mo. CME Term SOFR + 2.31%), 7.63%, 04/15/34 | | | | | | | 1,500 | | | | 1,500,884 | |
Battalion CLO X Ltd., Series 2016-10A, Class BR2, (3-mo. CME Term SOFR + 2.31%), 7.63%, 01/25/35(a)(b) | | | | | | | 1,000 | | | | 995,086 | |
Benefit Street Partners CLO XXVII Ltd., Series 2022- 27A, Class A1, (3-mo. CME Term SOFR + 1.80%), 7.12%, 07/20/35(a)(b) | | | | | | | 615 | | | | 618,942 | |
Bryant Park Funding Ltd., Series 2024-22A, Class C, (3-mo. CME Term SOFR + 2.60%), 7.91%, 04/15/37(a)(b) | | | | | | | 1,500 | | | | 1,500,000 | |
Canyon CLO Ltd., Series 2021-3A, Class B, (3-mo. CME Term SOFR + 1.96%), 7.28%, 07/15/34(a)(b) | | | | | | | 1,000 | | | | 996,220 | |
CarVal CLO II Ltd., Series 2019-1A, Class DR, (3-mo. CME Term SOFR + 3.46%), 8.78%, 04/20/32(a)(b) | | | | | | | 1,000 | | | | 995,742 | |
CarVal CLO IV Ltd., Series 2021-1A, Class D, (3-mo. CME Term SOFR + 3.51%), 8.83%, 07/20/34(a)(b) | | | | | | | 1,000 | | | | 978,157 | |
CIFC Funding Ltd.(a)(b) | | | | | | | | | | | | |
Series 2015-1A, Class CRR, (3-mo. CME Term SOFR + 2.16%), 7.48%, 01/22/31 | | | | | | | 1,000 | | | | 997,515 | |
Series 2019-1A, Class CR, (3-mo. CME Term SOFR + 2.31%), 7.63%, 04/20/32 | | | | | | | 1,000 | | | | 1,000,001 | |
Series 2019-5A, Class A2RS, (3-mo. CME Term SOFR + 2.01%), 7.33%, 01/15/35 | | | | | | | 800 | | | | 802,652 | |
Clover CLO LLC, Series 2020-1A, Class CR, (3-mo. CME Term SOFR + 2.26%), 7.58%, 04/15/34(a)(b) | | | | | | | 2,000 | | | | 1,997,984 | |
Cook Park CLO Ltd., Series 2018-1A, Class C, (3-mo. CME Term SOFR + 2.01%), 7.33%, 04/17/30(a)(b) | | | | | | | 250 | | | | 248,076 | |
Elmwood CLO 21 Ltd., Series 2022-8A, Class AR, (3-mo. CME Term SOFR + 1.65%), 6.97%, 10/20/36(a)(b) | | | | | | | 700 | | | | 701,488 | |
Elmwood CLO 26 Ltd, Series 2026-1A, Class C, (3-mo. CME Term SOFR + 2.40%), 7.69%, 04/18/37(a)(b) | | | | | | | 1,000 | | | | 1,000,000 | |
Flatiron CLO Ltd., Series 2021-1A, Class D, (3-mo. CME Term SOFR + 3.16%), 8.47%, 07/19/34(a)(b) | | | | | | | 1,000 | | | | 999,287 | |
Galaxy XXIV CLO Ltd., Series 2024-R, Class CR, (3-mo. CME Term SOFR + 2.45%), 7.77%, 04/15/37(a)(b) | | | | | | | 1,106 | | | | 1,108,550 | |
Generate CLO Ltd., Series 7A, Class A1R, (3-mo. CME Term SOFR + 1.62%), 6.92%, 04/22/37(a)(b) | | | | | | | 1,000 | | | | 1,000,549 | |
Golub Capital Partners LP, Series 2020-48A, Class C, (3-mo. CME Term SOFR + 3.06%), 8.38%, 04/17/33(a)(b) | | | | | | | 900 | | | | 900,033 | |